# US 2025/0375156 A1 · Methods and systems for heart health diagnostics

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0375156 A1
- Document ID: US20250375156A1
- Status: Published application
- Kind: A1
- Application number: 19/198,813
- Filed: 2025-05-05
- Published: 2025-12-11
- Earliest claimed: 2024-06-05
- Assignees: Pacesetter, Inc.
- Applicants: Pacesetter, Inc.
- Inventors: Gabriel A. Mouchawar; Jong Gill; Fady Dawoud; Fujian Qu
- Web page: https://patentgrep.com/patent/US20250375156A1

## CPC

- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 5/0205: Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B 5/024: Measuring pulse rate or heart rate
- A61B 5/1116: {Determining posture transitions}
- A61B 5/1118: {Determining activity level}
- A61B 5/686: {Permanently implanted devices, e.g. pacemakers, other stimulators, biochips (A61B5/6861 takes precedence)}
- A61B 5/6869: {Heart}
- A61B 5/7264: {Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems}
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- A61B 5/7282: {Event detection, e.g. detecting unique waveforms indicative of a medical condition (cough events A61B5/0823; seizures A61B5/4094; sleep apnoea A61B5/4818)}
- A61B 5/742: {using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339)}
- A61B 5/7475: {User input or interface means, e.g. keyboard, pointing device, joystick}
- A61N 1/365: controlled by a physiological parameter, e.g. heart potential {(evoked response A61N1/371)}
- A61N 1/36535: {controlled by body position or posture}
- A61N 1/36542: {controlled by body motion, e.g. acceleration}
- G16H 50/30: for calculating health indices; for individual health risk assessment
- A61B 2560/0462: Apparatus with built-in sensors
- A61B 2562/0219: Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

A system for monitoring a physiologic condition of a patient includes an implantable medical device (IMD) comprising: an accelerometer configured to output an accelerometer signal; sensing circuitry configured to sense a cardiac activity (CA) signal; and a memory configured to store program instructions. One or more processors that, when executing the program instructions, are configured to: determine a heart rate (HR) at a point in time based on the CA signal; determine an activity level (AL) at the point in time based on accelerometer data that is based on the accelerometer signal, the HR and AL forming an HR-AL event; compare the HR-AL event to a heart condition (HC) metric that defines combinations of HRs and ALs representing a physiologically normal heart condition and a physiologically abnormal heart condition; and transmit the HR-AL event or a result of the comparison to a second device for use in diagnosing and/or treating a heart condition.

## Claims

### Claim 1

A system for monitoring a physiologic condition of a patient, the system comprising:
an implantable medical device (IMD) configured to be implanted in the patient, the IMD comprising:
an accelerometer configured to output an accelerometer signal;
sensing circuitry configured to sense a cardiac activity (CA) signal over a plurality of cardiac cycles;
memory configured to store program instructions; and
one or more processors coupled to the accelerometer and the sensing circuitry that, when executing the program instructions, are configured to:
determine a heart rate (HR) at a point in time based on the CA signal;
determine an activity level (AL) at the point in time based on accelerometer data, the accelerometer data based on the accelerometer signal, the HR and AL forming an HR-AL event;
compare the HR-AL event to a heart condition (HC) metric that defines combinations of HRs and ALs representing a physiologically normal heart condition and a physiologically abnormal heart condition; and
transmit the HR-AL event or a result of the comparison to a second device, the HR-AL event or the result of the comparison utilized to treat a heart condition.

### Claim 2 (depends on 1)

The system of claim 1, wherein the one or more processors are further configured to:
repeat the determining and comparing operations to build an HC assessment data set;
save the HC assessment data set in the memory of the IMD; and
transmit the HC assessment data set to the second device, wherein the second device is an external device or a second IMD configured to be implanted in the patient, the HC assessment data set utilized to treat the heart condition.

### Claim 3 (depends on 2)

The system of claim 2, further comprising the second IMD, the second IMD further configured to deliver therapy to treat the physiologically abnormal heart condition designated by the HC assessment data set.

### Claim 4 (depends on 2)

The system of claim 2, further comprising an the external device configured to receive the HC assessment data set and map the HC assessment data set onto an HR-AL template to form a HC treatment profile, the external device having a display configured to display a graphical representation of the HC treatment profile.

### Claim 5 (depends on 4)

The system of claim 4, wherein the graphical representation of the HC treatment profile is divided into activity zones for i) no activity, ii) low activity, iii) moderate activity, and iv) high activity, and further divided into HR zones for i) low HR, ii) medium HR, and iii) high HR, the HC assessment data set mapped into the activity and HR zones.

### Claim 6 (depends on 4)

The system of claim 4, wherein the HC treatment profile includes a trend line indicating an increase in a number of the HR-AL events at a relatively higher HR over at least two activity levels.

### Claim 7 (depends on 4)

The system of claim 4, wherein the display is further configured to display a reference template in combination with the HC treatment profile, the reference template representing at least one of: i) an age-adjusted template, ii) a template associated with one of chronotropic incompetence, sick sinus syndrome, heart failure, fitness level of the patient, or fitness level of a population, or iii) a graphical representation based on a second HC assessment data set collected over a second monitoring period for the patient.

### Claim 8 (depends on 1)

The system of claim 1, wherein the HC metric includes upper and lower HC boundaries, wherein a range between the upper and lower HC boundaries corresponds to physiologically healthy HR-AL events, and the regions above the upper HC boundary and below the lower HC boundary correspond to physiologically unhealthy HR-AL events.

### Claim 9 (depends on 2)

The system of claim 2, wherein the one or more processors is further configured to delete the HR-AL events that fall within a range of the HC metric corresponding to the combinations of HRs and ALs representing the physiologically normal heart condition such that the HC assessment data set excludes the HR-AL events that fall within the range.

### Claim 10 (depends on 2)

The system of claim 2, wherein the one or more processors is further configured to save, in the HC assessment data set, the HR-AL events that fall in regions of the HC metric corresponding to the combinations of HRs and ALs representing the physiologically abnormal heart condition.

### Claim 11 (depends on 2)

The system of claim 2, wherein the HC assessment data set prescribes treatment for at least one of i) chronotropic incompetence, ii) sick sinus syndrome, iii) heart failure, iv) sleep apnea, or v) fitness level of the patient.

### Claim 12 (depends on 2)

The system of claim 2, wherein the HC assessment data set prescribes no treatment when the HC assessment data set is indicative of the physiologically normal heart condition.

### Claim 13 (depends on 2)

The system of claim 2, further comprising:
wherein the one or more processors is further configured to determine, using the accelerometer data, a posture from within a plurality of postures over the monitoring period; and
wherein each of the HR-AL events saved in the HC assessment data set in the memory is associated with the corresponding posture at the corresponding point in time.

### Claim 14 (depends on 13)

The system of claim 13, wherein the HC assessment data set excludes at least a portion of the HR-AL events associated with at least one of the postures.

### Claim 15

A computer implemented method for monitoring a physiologic condition of a patient utilizing an implantable medical device (IMD) configured to be implanted in the patient, the IMD comprising: an accelerometer, sensing circuitry, memory and one or more processors coupled to the accelerometer, the sensing circuitry, and the memory, the method comprising:
outputting an accelerometer signal utilizing the accelerometer;
sensing a cardiac activity (CA) signal over a plurality of cardiac cycles; and
utilizing the one or more processors that, when executing the program instructions, for:
determining a heart rate (HR) at a point in time based on the CA signal;
determining an activity level (AL) at the point in time based on accelerometer data, the accelerometer data based on the accelerometer signal, the HR and AL forming an HR-AL event;
comparing the HR-AL event to a heart condition (HC) metric that defines combinations of HRs and ALs representing a physiologically normal heart condition and a physiologically abnormal heart condition; and
transmitting the HR-AL event or a result of the comparison to a second device, the HR-AL event or the result of the comparison utilized to treat a heart condition.

### Claim 16 (depends on 15)

The method of claim 15, further comprising:
repeating the determining and comparing operations to build an HC assessment data set;
saving the HC assessment data set in the memory of the IMD; and
transmitting the HC assessment data set to the second device, wherein the second device is an external device or a second IMD configured to be implanted in the patient, the HC assessment data set utilized to treat the heart condition.

### Claim 17 (depends on 16)

The method of claim 16, further comprising delivering therapy, utilizing the second IMD, to treat the physiologically abnormal heart condition designated by the HC assessment data set.

### Claim 18 (depends on 16)

The method of claim 16, further comprising: receiving the HC assessment data set; mapping the HC assessment data set onto an HR-AL template to form a HC treatment profile; and displaying a graphical representation of the HC treatment profile.

### Claim 19 (depends on 18)

The method of claim 18, wherein the graphical representation of the HC treatment profile is divided into activity zones for i) no activity, ii) low activity, iii) moderate activity, and iv) high activity, and further divided into HR zones for i) low HR, ii) medium HR, and iii) high HR, the HC assessment data set mapped into the activity and HR zones.

### Claim 20 (depends on 18)

The method of claim 18, wherein the HC treatment profile includes a trend line indicating an increase in a number of the HR-AL events at a relatively higher HR over at least two activity levels.

### Claim 21 (depends on 18)

The method of claim 18, further comprising displaying a reference template in combination with the HC treatment profile, the reference template representing at least one of: i) an age-adjusted template, ii) a template associated with one of chronotropic incompetence, sick sinus syndrome, heart failure, fitness level of the patient, or fitness level of a population, or iii) a graphical representation based on a second HC assessment data set collected over a second monitoring period for the patient.

### Claim 22 (depends on 15)

The method of claim 15, wherein the HC metric includes upper and lower HC boundaries, wherein a range between the upper and lower HC boundaries corresponds to physiologically healthy HR-AL events, and the regions above the upper HC boundary and below the lower HC boundary correspond to physiologically unhealthy HR-AL events.

### Claim 23 (depends on 16)

The method of claim 16, further comprising deleting the HR-AL events that fall within a range of the HC metric corresponding to the combinations of HRs and ALs representing the physiologically normal heart condition such that the HC assessment data set excludes the HR-AL events that fall within the range.

### Claim 24 (depends on 16)

The method of claim 16, further comprising saving, in the HC assessment data set, the HR-AL events that fall in regions of the HC metric corresponding to the combinations of HRs and ALs representing the physiologically abnormal heart condition.

### Claim 25 (depends on 16)

The method of claim 16, wherein the HC assessment data set prescribes treatment for at least one of i) chronotropic incompetence, ii) sick sinus syndrome, iii) heart failure, iv) sleep apnea, or v) fitness level of the patient.

### Claim 26 (depends on 16)

The method of claim 16, wherein the HC assessment data set prescribes no treatment when the HC assessment data set is indicative of the physiologically normal heart condition.
